Tuberculosis Burden Remains High


BMI View: While prevalence rates can provide much insight on the extent of a disease in a country, the data can be very patchy - particularly in developing countries that do not have the resources to record data accurately and consistently. Alternatively, BMI highlights that disability-adjusted life years (DALYs) is another indicator that can be used by pharmaceutical firms, government agencies and healthcare providers to understand shortcomings in terms of access to drugs. This in turn enables companies and authorities to plan investments and policies accordingly.

The World Health Organization (WHO) has released the 'Global Tuberculosis (TB) Report 2013'. The report shows that instances of new TB cases has been falling globally, although the rate of decline - just 2% annually - remains slow. Other findings include:

  • The Americas and Western Pacific regions achieved their 2015 targets to reduce incidence, prevalence and mortality of TB. However, the African and European regions are not on track to achieve these targets.

  • Cambodia Has Highest TB Prevalence
    TB Prevalence Rate (Per 100,000 Population) In Selected Asian Countries

or Register now for free to read the full article

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare
Geography: Asia, China